{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:05:12Z","timestamp":1793624712278,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The incidence and prevalence of clinical Alzheimer disease (AD) are higher among Black and Latinx older adults than among White older adults. Past studies that compared plasma AD biomarker concentrations among groups minoritized by their race and ethnicity yielded inconsistent findings; however, these efforts did not include population representative samples or statistical procedures to ensure population representation.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine race and ethnicity differences in plasma AD biomarker concentrations and in the association between biomarkers and medical conditions in a US population-representative cohort of middle-aged adults (approximately 58 years of age).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Data for this cohort study came from the High School and Beyond sample, a nationally representative cohort of high school sophomores and seniors who were recruited in 1980. In 2021, a subset of participants provided blood samples that were assayed for amyloid-\u03b2 (A\u03b242\/A\u03b240 ratio), phosphorylated tau-181 (pTau-181), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP). The analyses for the present study were conducted between July 2, 2024, and August 26, 2025, using data collected during the 2021 follow-up study.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Race and ethnicity groups and common medical conditions.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n General linear models with Wald tests were used to compare biomarker concentrations between race and ethnicity groups and to test interactions with common medical conditions using unadjusted biomarker values and models adjusted to ensure population representation with inverse probability weighting and multiple imputation.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The sample included 4340 adults (mean [SD; range] age, 58.1 [1.1; 56-63] years; 2400 [55.3%] women); 630 (14.4%) were Black, 900 (20.7%) were Latinx, and 2610 (60.1%) were White. Black participants had a lower A\u03b242\/A\u03b240 ratio (\n d<\/jats:italic>\n \u2009=\u2009\u20130.002; 95% CI, \u20130.004 to \u20130.000;\n P<\/jats:italic>\n \u2009=\u2009.04) and lower NfL concentrations (\n d<\/jats:italic>\n \u2009=\u2009\u20131.16; 95% CI, \u20132.15 to \u20130.16;\n P<\/jats:italic>\n \u2009=\u2009.02) than White participants, but these differences were attenuated when models were adjusted for population representation (\n d<\/jats:italic>\n \u2009=\u20090.000; 95% CI, \u20130.002 to 0.002;\n P<\/jats:italic>\n \u2009=\u2009.85 for A\u03b2 ratio;\n d<\/jats:italic>\n \u2009=\u2009\u22120.88; 95% CI, \u20131.78 to 0.02;\n P<\/jats:italic>\n \u2009=\u2009.05 for NfL). Latinx participants had lower GFAP concentrations than White participants (\n d<\/jats:italic>\n \u2009=\u2009\u22123.87; 95% CI, \u20137.30 to \u20130.45;\n P<\/jats:italic>\n \u2009=\u2009.03), but these differences were also attenuated when models were adjusted for population representation (\n d<\/jats:italic>\n \u2009=\u20093.36; 95% CI, \u20133.13 to 9.86;\n P<\/jats:italic>\n \u2009=\u2009.31). In general, estimated biomarker means were similar between race and ethnicity groups. History of type 2 diabetes was associated with increased NfL concentration (\n d<\/jats:italic>\n \u2009=\u20090.19; 95% CI, 0.07 to 0.30;\n P<\/jats:italic>\n \u2009=\u2009.04), and high body mass index was associated with lower A\u03b242\/A\u03b240 ratio (\n d<\/jats:italic>\n \u2009=\u2009\u22120.13; 95% CI, \u22120.21 to \u22120.06;\n P<\/jats:italic>\n \u2009=\u2009.02); whereas high cholesterol was associated with lower pTau-181 concentration (\n d<\/jats:italic>\n \u2009=\u2009\u22120.18; 95% CI, \u22120.25 to \u22120.10;\n P<\/jats:italic>\n \u2009=\u2009.01) and high BMI was associated with lower GFAP concentration (\n d<\/jats:italic>\n \u2009=\u2009\u22120.30; 95% CI \u22120.44 to \u22120.16;\n P<\/jats:italic>\n \u2009=\u2009.01). No differences in associations between morbidities and AD biomarker concentrations were detected across race and ethnicity groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort of middle-aged adults, the use of appropriate statistical estimation to ensure population representation indicated that blood-based AD biomarker concentrations were not distinguishable among race and ethnicity groups. Common medical conditions were associated with plasma biomarker concentrations similarly across race and ethnicity groups. These results highlight the importance of considering population representation and comorbid conditions in AD research to ensure accurate characterization of disease pathophysiology and improve precision of diagnostic and treatment strategies for populations that experience AD disparities.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.45046","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:37Z","timestamp":1763742637000},"page":"e2545046","source":"Crossref","is-referenced-by-count":10,"title":["Alzheimer Disease Blood Biomarker Concentrations Across Race and Ethnicity Groups in Middle-Aged Adults"],"prefix":"10.1001","volume":"8","author":[{"given":"Adam M.","family":"Brickman","sequence":"first","affiliation":[{"name":"Taub Institute for Research on Alzheimer\u2019s Disease & the Aging Brain, G.H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York"},{"name":"Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Sociology, University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Robert","family":"Warren","sequence":"additional","affiliation":[{"name":"Institute for Social Research and Data Innovation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grodsky","sequence":"additional","affiliation":[{"name":"Department of Sociology, University of Wisconsin-Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soobin","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Demography of Health and Aging, University of Wisconsin-Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Culbertson","sequence":"additional","affiliation":[{"name":"Center for Demography of Health and Aging, University of Wisconsin-Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Thyagarajan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Manly","sequence":"additional","affiliation":[{"name":"Taub Institute for Research on Alzheimer\u2019s Disease & the Aging Brain, G.H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York"},{"name":"Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"7","key":"zoi251217r1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"8","key":"zoi251217r2","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup.","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"22","key":"zoi251217r3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/WNL.0000000000007583","article-title":"A brief history of \u201cAlzheimer disease\u201d: Multiple meanings separated by a common name.","volume":"92","author":"Knopman","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"zoi251217r4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/cclm-2023-1434","article-title":"Blood-based biomarkers in Alzheimer\u2019s disease - moving towards a new era of diagnostics.","volume":"62","author":"Arslan","year":"2024","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"zoi251217r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2024.07.013","article-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease.","volume":"5","author":"Sch\u00f6ll","year":"2024","journal-title":"Lancet Healthy Longev"},{"issue":"3","key":"zoi251217r6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","article-title":"Inequalities in dementia incidence between six racial and ethnic groups over 14 years.","volume":"12","author":"Mayeda","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"4","key":"zoi251217r7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer\u2019s disease facts and figures.","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"7","key":"zoi251217r8","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1002\/alz.13027","article-title":"The structural and social determinants of Alzheimer\u2019s disease related dementias.","volume":"19","author":"Adkins-Jackson","year":"2023","journal-title":"Alzheimers Dement"},{"key":"zoi251217r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14283\/jarlife.2024.1","article-title":"Association between modifiable risk factors and levels of blood-based biomarkers of Alzheimer\u2019s and related dementias in the Look AHEAD Cohort.","volume":"13","author":"Hayden","year":"2024","journal-title":"JAR Life"},{"issue":"1","key":"zoi251217r10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/13872877241299047","article-title":"Ethnic and racial influences on blood biomarkers for Alzheimer\u2019s disease: A systematic review.","volume":"103","author":"Kjaergaard","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"zoi251217r11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.871947","article-title":"Characterizing plasma biomarkers of Alzheimer\u2019s in a diverse community-based cohort: a cross-sectional study of the HAB-HD cohort.","volume":"13","author":"Hall","year":"2022","journal-title":"Front Neurol"},{"issue":"10","key":"zoi251217r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.35068","article-title":"Association of plasma and cerebrospinal fluid Alzheimer disease biomarkers with race and the role of genetic ancestry, vascular comorbidities, and neighborhood factors.","volume":"5","author":"Hajjar","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi251217r13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","article-title":"Alzheimer disease blood biomarkers: considerations for population-level use.","volume":"20","author":"Mielke","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"zoi251217r14","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1212\/WNL.0000000000200358","article-title":"Effect of race on prediction of brain amyloidosis by plasma A\u00df42\/A\u00df40, phosphorylated tau, and neurofilament light.","volume":"99","author":"Schindler","year":"2022","journal-title":"Neurology"},{"issue":"14","key":"zoi251217r15","doi-asserted-by":"publisher","first-page":"e1402","DOI":"10.1212\/WNL.0000000000207675","article-title":"Association of plasma biomarkers of Alzheimer disease with cognition and medical comorbidities in a biracial cohort.","volume":"101","author":"Ramanan","year":"2023","journal-title":"Neurology"},{"issue":"8","key":"zoi251217r16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study.","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"zoi251217r17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer disease.","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol"},{"issue":"11","key":"zoi251217r18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2022.3157","article-title":"Racial and ethnic differences in amyloid pet positivity in individuals with mild cognitive impairment or dementia: a secondary analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) cohort study.","volume":"79","author":"Wilkins","year":"2022","journal-title":"JAMA Neurol"},{"issue":"7","key":"zoi251217r19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.19672","article-title":"Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US.","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi251217r21","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1093\/ije\/dyac044","article-title":"Cohort Profile: High School and Beyond.","volume":"51","author":"Grodsky","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"2","key":"zoi251217r23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3233\/JAD-230384","article-title":"Pre-analytical variables influencing stability of blood-based biomarkers of neuropathology.","volume":"95","author":"Panikkar","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"zoi251217r26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1177\/00491241221113873","article-title":"A comparison of three popular methods for handling missing data: complete-case analysis, inverse probability weighting, and multiple imputation.","volume":"53","author":"Little","year":"2024","journal-title":"Sociol Methods Res"},{"issue":"4","key":"zoi251217r30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"1","key":"zoi251217r31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"2","key":"zoi251217r32","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70015","article-title":"Education and midlife cognitive functioning: evidence from the High School and Beyond cohort.","volume":"21","author":"Muller","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"zoi251217r33","article-title":"Representativeness of samples enrolled in Alzheimer\u2019s disease research centers.","volume":"15","author":"Arce Renter\u00eda","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"zoi251217r34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction-The disregarded partner of Alzheimer\u2019s disease.","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"5","key":"zoi251217r35","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae331","article-title":"Cerebrovascular disease is associated with Alzheimer\u2019s plasma biomarker concentrations in adults with Down syndrome.","volume":"6","author":"Edwards","year":"2024","journal-title":"Brain Commun"},{"issue":"1","key":"zoi251217r36","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1038\/s41598-022-11557-2","article-title":"Circulating neurofilament is linked with morbid obesity, renal function, and brain density.","volume":"12","author":"Rebelos","year":"2022","journal-title":"Sci Rep"},{"key":"zoi251217r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annepidem.2018.09.007","article-title":"How do we assess a racial disparity in health? Distribution, interaction, and interpretation in epidemiological studies.","volume":"29","author":"Ward","year":"2019","journal-title":"Ann Epidemiol"},{"issue":"12","key":"zoi251217r38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","article-title":"APOE genotype and Alzheimer disease risk across age, sex, and population ancestry.","volume":"80","author":"Belloy","year":"2023","journal-title":"JAMA Neurol"},{"issue":"5123","key":"zoi251217r39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"7","key":"zoi251217r40","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41593-024-01669-5","article-title":"Apolipoprotein E in Alzheimer\u2019s disease trajectories and the next-generation clinical care pathway.","volume":"27","author":"Narasimhan","year":"2024","journal-title":"Nat Neurosci"},{"issue":"5","key":"zoi251217r41","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1212\/WNL.0000000000002914","article-title":"The ARIC-PET amyloid imaging study: brain amyloid differences by age, race, sex, and APOE.","volume":"87","author":"Gottesman","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"zoi251217r42","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae162","article-title":"Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET.","volume":"6","author":"De Meyer","year":"2024","journal-title":"Brain Commun"},{"key":"zoi251217r24","volume-title":"Applied Survey Data Analysis","author":"Berglund","year":"2017"},{"key":"zoi251217r27","volume-title":"Statistical Analysis with Missing Data","author":"Little","year":"2019"},{"key":"zoi251217r28","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"key":"zoi251217r29","doi-asserted-by":"crossref","DOI":"10.1201\/b11826","volume-title":"Flexible Imputation of Missing Data","author":"Van Buuren","year":"2012"},{"key":"zoi251217r20","unstructured":"Frankel? MR. High School and Beyond: A national longitudinal study for the 1980\u2019s. sample design report. 1981. Accessed October 8, 2025. https:\/\/eric.ed.gov\/?id=ED214990"},{"key":"zoi251217r22","unstructured":"Warren? J, Grodsky? E. Cohort profile update: High School and Beyond (CDE working paper No. 2025-01). Center for Demography and Ecology, University of Wisconsin-Madison. 2025. Accessed October 8, 2025. https:\/\/edshareproject.org\/sites\/edshareproject.org\/files\/2025-09\/HSB_80-2021_Updated_Cohort_Profile.pdf"},{"key":"zoi251217r25","unstructured":"Jones? CC, Spencer? BD. High School and Beyond: second follow-up (1984) sample design report. The National Opinion Research Center. Accessed October 8, 2025. https:\/\/files.eric.ed.gov\/fulltext\/ED622024.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2841743\/brickman_2025_oi_251217_1763141585.55852.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:39Z","timestamp":1763742639000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2841743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.45046","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}